Insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Asian patients with type 2 diabetes inadequately controlled on basal or pre-/self-mixed insulin: a 26-week, randomised, treat-to-target trial (Q41701305)

From Wikidata
Jump to navigation Jump to search
scientific article published on 14 October 2014
edit
Language Label Description Also known as
English
Insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Asian patients with type 2 diabetes inadequately controlled on basal or pre-/self-mixed insulin: a 26-week, randomised, treat-to-target trial
scientific article published on 14 October 2014

    Statements

    Insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Asian patients with type 2 diabetes inadequately controlled on basal or pre-/self-mixed insulin: a 26-week, randomised, treat-to-target trial (English)
    Shizuka Kaneko
    Francis Chow
    Dong Seop Choi
    Shinji Taneda
    Koichi Hirao
    Yongsoo Park
    Thomas Hasseriis Andersen
    Mari-Anne Gall
    Jens Sandahl Christiansen
    BOOST: Intensify All Trial Investigators
    14 October 2014
    139-147

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit